How about a free demo of the Simcyp™ PBPK Simulator? Complete the form to book your no-obligation demo of the standard software for Population-based Physiologically Based Modeling and Simulation… and see how better off you could be with Simcyp!
https://www.certara.com/thank-you-pbpk-applications-mifd-using-the-simcyp-simulator-ebook/Join us in this episode of CertaraTalks as Roman Casciano and Ananth Kadambi discuss the key highlights from ISPOR Europe 2023. Watch below for insights and key takeaways around topics like the European health data space and the use of AI for health technology assessment. Transcript Hello, and welcome to Certara Talks. I’m Doctor Suzanne … Continued
https://www.certara.com/podcast/certara-talks-ispor-europe-2023/The latest episode of CertaraTalks features Dr. Mirjam Trame and Dr. Piet van der Graaf being interviewed by Dr. Suzanne Minton on the key moments from the annual meeting of the American Conference on Pharmacometrics, ACoP14! Explore highlights ranging from the dynamic ISOP Trainee Communications Challenge to the groundbreaking use of ArtificialIntelligence in Quantitative Systems … Continued
https://www.certara.com/podcast/certara-talks-acop-2023-recap/In the latest CertaraTalks episode, Krista K. Greenwood, PhD, DABT, Director of Toxicology at Certara, shares key insights from the American College of Toxicology 2023 Annual Meeting. Explore highlights like Project Optimus, the FDA’s groundbreaking dose optimization initiative for oncology products, and updates on the latest safety pharmacology best practices. Transcript: Introduction Welcome. You’re watching … Continued
https://www.certara.com/podcast/certara-talks-act-2023-recap/Laura Sheppard joins this episode of #CertaraTalks to share highlights from #AMWA2023. Watch below for insights and key takeaways around topics like AI and the evolution of technology in medical writing and the importance of plain language summaries. Video Transcript: Hello, everybody. I’m Doctor. Suzanne Minton. I’m a director of content strategy at Sartara, and … Continued
https://www.certara.com/podcast/certara-talks-amwa-2023/PRINCETON, N.J., Feb. 01, 2024 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the fourth quarter and full year of 2023 after the market close on Thursday, February 29th, 2024. Company management will host a conference call to discuss financial results at … Continued
https://www.certara.com/pressrelease/certara-to-report-fourth-quarter-and-full-year-2023-financial-results-on-february-29th-2024-and-participate-in-the-barclays-26th-annual-global-healthcare-conference/The educational webinar will present the process of obtaining market access and reimbursement in the US, France and Germany as well as on the upcoming a Joint Clinical Assessment (JCA) process. In the US, we will be discussing the stakeholders that are involved in product access given the fragmented US payer system (e.g. Commercial, Medicare, … Continued
https://www.certara.com/on-demand-webinar/how-to-obtain-market-access-and-reimbursement-in-the-united-states-france-and-germany/This blog defines the global value dossiers and explains how BaseCase can support creating interactive value-creation tools.
https://www.certara.com/blog/navigating-market-access-for-healthcare-products-the-power-of-the-global-value-dossier/Join the worldwide Phoenix user community and the Certara Phoenix team to learn how our solutions are accelerating drug development. The meeting will include presentations from Phoenix users and updates on the Phoenix vision and roadmap. Location Convene CityView, 30 S 17th St, Philadelphia, PA 19103 Agenda 9am: Welcome 9:15am – 10am: Product Overview, Vision, and Roadmap 10am – … Continued
https://www.certara.com/live-events/phoenix-ugm-2024/If you work at a biotechnology start-up, you’re probably excited about your compound assets, particularly if your development program has a single asset. Unfortunately, navigating the ocean of opportunity can become more of a pain than a blessing, especially when your disease area has significant investor activity. Focusing your excitement is essential! It’s beneficial to … Continued
https://www.certara.com/blog/understanding-the-role-of-your-discovery-assets-target-product-profile/